Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test

Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test

Abstract Background A 31-gene expression profile (GEP) test that provides risk classification of cutaneous melanoma (CM) patients has been validated in several retrospective studies. The objective of the reported study was a prospective evaluation of the GEP performance in patients enrolled in two c...

Full description

Bibliographic Details
Main Authors: Eddy C. Hsueh, James R. DeBloom, Jonathan Lee, Jeffrey J. Sussman, Kyle R. Covington, Brooke Middlebrook, Clare Johnson, Robert W. Cook, Craig L. Slingluff, Kelly M. McMasters
Format: Article
Language:English
Published: BMC 2017-08-01
Series:Journal of Hematology & Oncology
Subjects:
Gene expression profiling
DecisionDx-Melanoma
Cutaneous melanoma
Metastasis
Prognosis
Staging
Online Access:http://link.springer.com/article/10.1186/s13045-017-0520-1

Similar Items

Similar Items